Skip to main content
    S

    Solventum Corp. (SOLV)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $86.30
    +0.99 (+1.16%)

    Market Cap: $14.85B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(9/10)
    Avg Surprise
    +11.32%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.35
    Range$1.29 - $1.43
    11 analysts
    EPS Revisions
    1
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$1.41-4.1%
    60d ago$1.35+0.3%
    30d ago$1.35+0.1%
    7d ago$1.350.0%
    Current$1.35
    Revenue Consensus
    $1.9B
    Range$1.9B - $2.0B
    11 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.53
    Range$1.94 - $2.94
    15 analysts
    Revenue Consensus
    $2.2B
    Range$2.0B - $2.2B
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.53---
    Sep 26EST
    		-$1.35---
    Jun 26
    Reported Aug 5
    		$2.55$1.91+33.51%Beat+50.9%
    Mar 26
    Reported May 5
    		$1.48$1.35+9.63%Beat+10.4%
    Dec 25
    Reported Feb 26
    		$1.57$1.50+4.67%Beat+11.3%
    Sep 25
    Reported Nov 6
    		$1.50$1.43+4.90%Beat-8.5%
    Jun 25
    Reported Aug 7
    		$1.69$1.45+16.55%Beat+8.3%
    Mar 25
    Reported May 8
    		$1.34$1.22+9.84%Beat-35.6%
    Dec 24
    Reported Feb 27
    		$1.41$1.50-6.00%Miss-39.0%
    Sep 24
    Reported Nov 7
    		$1.64$1.39+17.99%Beat-
    Jun 24
    Reported Aug 8
    		$1.56$1.51+3.31%Beat-
    Mar 24
    Reported May 9
    		$2.08$1.75+18.86%Beat-
    Dec 23
    Reported Feb 28
    		$2.31$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio12.15EV/EBITDA7.68x
    Price/FCF-126.31xFCF Yield-0.79%
    Profitability
    Profit Margin17.30%Operating Margin9.78%
    ROE34.00%ROIC17.51%
    Financial Health
    Debt/Equity1.06xInterest Coverage26.12x
    Current Ratio1.02xQuick Ratio0.74x
    Trading Statistics
    Beta0.70Avg Volume963.20K
    52-Week High$94.1652-Week Low$62.38

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$87.00
    SMA 20$87.91
    SMA 50$88.38
    SMA 200$78.16
    EMA 10$86.95
    EMA 20$87.63
    EMA 50$86.95
    EMA 200$80.29

    MACD

    Line: -0.62Signal: -0.28Hist: -0.33

    ADX

    ADX: 17.0+DI: 14.8-DI: 29.7

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down100.0
    PSAR$88.59

    Bollinger Bands

    Upper Band$90.34
    Lower Band$85.47
    %B Position555%(Upper)
    Band Width0.17

    RSI (14-Day)

    Neutral
    43.2

    Momentum Oscillators

    Stoch %K35.3
    Stoch %D30.3
    Williams %R-54.4
    ROC (10d)-3.4%
    Momentum-3.02
    CCI (20d)-177.2
    MFI (14d)40.0

    Volatility Measures

    ATR (14d)$2.10(2.4%)
    StdDev (20d)1.22
    Hist Vol16.2%(Low)

    Volume Flow

    VWAP$85.36
    OBV6.8M
    AD Line3.5M
    CMF (20d)-0.070

    Volume Metrics

    Avg Vol (20d)965.4K
    Vol Ratio1.0x
    VWMA (20d)$87.77

    Pivot Points

    R3$91.42
    R2$89.84
    R1$87.58
    Pivot Point$86.00
    S1$83.73
    S2$82.15
    S3$79.89

    Advanced Oscillators

    TSI-11.47
    Ultimate Osc49.4
    KST-21.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.21B$2.01B$2.00B$2.10B$2.16B$2.07B$2.08B$2.08B$2.08B$2.02B$2.04B$2.07B
    Cost of Revenue$923.00M$911.00M$971.00M$961.00M$986.00M$956.00M$956.00M$917.00M$944.00M$844.00M$878.00M$865.00M
    Gross Profit$1.29B$1.10B$1.03B$1.14B$1.18B$1.11B$1.12B$1.17B$1.14B$1.17B$1.16B$1.21B
    Operating Expenses$1.10B$1.02B$902.00M$-555,000,000$961.00M$962.00M$983.00M$890.00M$893.00M$791.00M$752.00M$705.00M
    R&D$178.00M$189.00M$174.00M$183.00M$189.00M$193.00M$199.00M$189.00M$192.00M$195.00M$190.00M$180.00M
    SG&A$927.00M$827.00M$759.00M$780.00M$772.00M$769.00M$784.00M$701.00M$701.00M$596.00M$618.00M$525.00M
    Operating Income$181.00M$81.00M$125.00M$1.69B$214.00M$152.00M$136.00M$275.00M$244.00M$381.00M$406.00M$504.00M
    Interest Income$-64,000,000$-62,000,000$-51,000,000$-89,000,000$-103,000,000$-104,000,000$-107,000,000$-107,000,000$-114,000,000$-39,000,000$0$0
    Interest Expense$73.00M$65.00M$67.00M$82.00M$111.00M$114.00M$123.00M$0$148.00M$52.00M$15.00M$4.00M
    Income Before Tax$108.00M$16.00M$58.00M$1.51B$103.00M$38.00M$13.00M$167.00M$96.00M$329.00M$391.00M$500.00M
    Income Tax Expense$15.00M$3.00M$-5,000,000$248.00M$13.00M$-99,000,000$-17,000,000$45.00M$7.00M$92.00M$119.00M$40.00M
    Net Income$92.00M$13.00M$63.00M$1.27B$90.00M$137.00M$31.00M$122.00M$89.00M$237.00M$272.00M$460.00M
    EBITDA$305.00M$212.00M$227.00M$1.81B$328.00M$270.00M$270.00M$407.00M$343.00M$507.00M$530.00M$644.00M
    EBIT$172.00M$77.00M$110.00M$1.69B$206.00M$141.00M$120.00M$274.00M$210.00M$368.00M$391.00M$500.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SOLV

    News

    If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now

    An investment of $1000 in Thermo Fisher Scientific (TMO) a decade ago would now be worth $4,590.93, representing a 359.09% gain...

    Yahoo Finance•10/16/26•Neutral

    SOLN5957968 Bond Profile: Coupon and Redemption

    This article provides a detailed bond profile for Solventum Corporation's 5.6% bond, maturing on March 23, 2034, with the symbol SOLN5957968. It outlines key facts such as the issuer, issue date, maturity date...

    TradingView•10/16/26•Neutral

    At 4:30 p.m. Eastern on Nov. 5, Solventum will discuss its quarterly results.

    Solventum (NYSE: SOLV) is scheduled to release its third-quarter fiscal 2026 financial results on November 5, 2026, after the U.S. financial markets close. Following the release...

    Stock Titan•10/15/26•Neutral

    Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026

    Solventum (NYSE: SOLV) announced it will release its third quarter fiscal 2026 financial results on Thursday, November 5, 2026, after the U.S. financial markets close. Following the release...

    Yahoo Finance•10/15/26•Neutral

    Solventum Corp. stock rises Wednesday, outperforms market

    Solventum Corp. (SOLV) shares increased by 1.11% on Wednesday, closing at $87.26. This rise occurred during a generally negative trading session where the S&P 500 and Dow Jones Industrial Average both experienced...

    MarketWatch•10/14/26•Bullish

    SOLV Valuation and Fair Value

    P/E
    12.2x
    Forward P/E
    13.1x
    EV/EBITDA
    7.7x
    P/FCF
    -126.3x
    PEG
    1.2x
    P/B
    3.1x
    See GNG's fair value

    SOLV Profitability: Margins, ROIC and FCF

    Gross margin
    54.7%
    Operating margin
    9.8%
    Net margin
    17.3%
    ROIC
    17.5%
    ROE
    34.0%
    FCF margin
    -1.4%
    FCF yield
    -0.8%

    SOLV Competitors

    CompanyTicker
    Exelixis IncEXEL
    Ascendis Pharma ASASND
    Revvity Inc.RVTY
    Charles River LaboratoriesCRL
    Medpace Holdings IncMEDP
    Neurocrine Biosciences IncNBIX
    Hologic IncHOLX
    Jazz Pharmaceuticals PLCJAZZ

    Sector: Healthcare

    SOLV Analyst Ratings

    Consensus
    Hold
    Analysts
    15
    Strong Buy
    1
    Buy
    7
    Hold
    5
    Sell
    1
    Strong Sell
    1

    SOLV Bull Case vs Bear Case

    Bull case

    • SOLV earns a 17.5% return on invested capital.
    • SOLV beat EPS estimates in 87.5% of its last 8 reported quarters.

    SOLV Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    11.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.35
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    Frequently Asked Questions About SOLV

    Does SOLV pay dividends?

    Solventum Corp. (SOLV) does not currently pay a regular dividend.

    What is SOLV's P/E ratio?

    Solventum Corp. has a price-to-earnings (P/E) ratio of 12.15.

    What is SOLV's market cap?

    Solventum Corp. (SOLV) has a market capitalization of $14.85B with a current stock price of $86.30.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In